|
Mr. McEwan was hired as Chief Financial Officer in September 2005. Prior to working at Cornerstone, Mr. McEwan was a Group Executive Vice President of Inveresk Research Group, Inc. and served as President of Inveresk Global Clinical Operations beginning in 2003. He had previously been President of Inveresk Clinical Americas operations since April 2001. Mr. McEwan was Head of Corporate Development of Inveresk Research Group from January 2000 until March 2001, focusing on mergers and acquisitions, and served as General Manager, Clinical, of Inveresk Research Group Limited from June 1996 until December 1999, with significant operational responsibility. Mr. McEwan was instrumental in Inveresk’s acquisition of ClinTrials Research, Inc. in 2001, which tripled the size of Inveresk at the time. Mr. McEwan served as a member of the Group Executive Board of Inveresk Research Inc. from 1999 to 2004, during which time he had direct involvement in Inveresk’s initial public offering, subsequent acquisitions, and eventual sale to Charles River Laboratories for $1.5 billion. Mr. McEwan qualified as a Chartered Accountant in 1979 with the Institute of Chartered Accountants of Scotland after receiving a Bachelor of Commerce degree in 1976 from the University of Edinburgh. | 